- Book
- July 2023
- 304 Pages
- Book
- April 2022
- 288 Pages
- Book
- February 2019
- 480 Pages
- Book
- July 2018
- 320 Pages
- Book
- October 2014
- 296 Pages
- Book
- April 2014
- 432 Pages
- Book
- April 2013
- 720 Pages
- Book
- February 2008
- 1350 Pages
- Book
- January 2008
- 453 Pages
- Book
- January 2008
- 460 Pages
- Book
- January 2008
- 311 Pages
- Book
- January 2025
- 464 Pages

Tuberculosis (TB) is an infectious disease caused by the bacterium Mycobacterium tuberculosis. It is a major public health concern, particularly in developing countries, and is the leading cause of death from a single infectious agent. TB is typically diagnosed through a combination of clinical symptoms, chest X-rays, and laboratory tests. Infectious disease testing for TB is used to detect the presence of the bacteria in a patient's sample. Tests may include sputum smear microscopy, culture, and nucleic acid amplification tests.
The TB testing market is expected to grow due to increasing prevalence of TB, rising awareness of TB diagnosis, and technological advancements in TB testing. The market is segmented by product type, end user, and geography.
Companies in the TB testing market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, Qiagen, Roche Diagnostics, Siemens Healthineers, and Thermo Fisher Scientific. Show Less Read more